Depression, AnxietyVIDACTIVA1NCT06065020
Community Intervention to Improve Depressive Symptoms Among Older Adults (VIDACTIVA)
A study testing VIDACTIVA sessions in people with Depression, Anxiety, run by Universidad de San Martín de Porres at 1 site in Peru.
Trial summary
The goal of this pilot trial is to test how feasible is to conduct a large clinical trial that evaluate both implementation and effectiveness outcomes of a community-based interventions for older adults with depression in low-resource urban settings from Lima, Peru. Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Depression, Anxiety
- What is being tested?
- VIDACTIVA sessions
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 72 participants
- Where
- 1 sitePeru
- Study dates
- 23 Oct 2023to 3 Feb 2025
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Having depressive symptoms (score equal to or greater than 6 on the Patient Health Questionnaire - PHQ 9).
- Capacity to give consent.
- Current residence in Villa El Salvador, Lima, Peru.
Who cannot join
- Previous diagnosis of bipolar disorder
- History of substance abuse
- History of dissociative disorder, psychosis or dementia, or moderate memory and/or cognition problems.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Pilot Trial of an Evidence-based Community Intervention to Improve Depressive Symptoms Among Peruvian Older Adults
The goal of this pilot trial is to test how feasible is to conduct a large clinical trial that evaluate both implementation and effectiveness outcomes of a community-based interventions for older adults with depression in low-resource urban settings from Lima, Peru.
The main questions:
Is the way we are planning the study, including those who are taking part and what they will do, good for a large study?
Is the interventional package we are developing good the way it is, and can it be done the way we planned it?
Read the detailed description
Participants who join will be split into two groups: one group will get the interventional program, and the other group will get standard care. In the interventional group, community health workers will meet with participants eight times to do activities and talk about how they feel. The standard group will have two visits where they will learn things about mental health.
The results of the study will help the researchers understand whether they can test the program in larger study. Additionally, see whether those participants in the interventional group feel better than those who are in the standard group.
Sample size: This is a pilot trial. No sample size calculations are needed because the objective is NOT to evaluate the effect of the intervention, but rather the feasibility of conducting a large-scale clinical trial. It is expected to enroll 64 participants (32 control group vs 32 intervention group). This number is based on previous formative study and training of community health workers.
Researchers will collect basic information to assess feasibility for a larger trial, including:
- Number of potential participants screened per month;
- Number of participants enroled per month;
- Average time from enrolment to randomisation.
- Average time to reach enrolment goal
- Proportion of eligible participants who enrol
- Proportion of people who maintain the study in both groups.
- Reasons for abandoning the study.
- Visit durations
- Conditions
- Depression, Anxiety
- Being tested
- VIDACTIVA sessions, Standard Care
- Keywords
- depression, aged, problem-solving
- Medical subject headings
- Depression, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
VIDACTIVA sessionsBehavioural
Community health workers (CHWs) will delivered VIDACTIVA intervention that consists in 8 home-sessions, one hour duration, within a period of 14 weeks + 2 follow-up calls (monthly). In total, a period of 22 weeks.
The multicomponent intervention consist in the following:
Problem-Solving Exercises: These are basic structured exercises aimed at training older individuals in problem-solving. This activity is centered around the older adult, meaning the older adults guides this activity, and the CHWs is a facilitator.
Physical Activation: This component involves planning and "scheduling" enjoyable activities (physical or social) that the older adult chooses based on their preferences and capabilities.
Education on Depressive Symptoms (psychoeducation)
Standard CareBehavioural
Study fieldworkers will provide 2 educational sessions (45-60 min) about mental health at old age and participant will be guided to mental health community services (primary care centers). One session after the enrolment (week 1) and one at the 14th week.
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | VIDACTIVA program Receives: Behavioral: VIDACTIVA sessions |
| Control group | Active comparator | Standard Care Receives: Behavioral: Standard Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Depressive Symptoms
Measured by Patient Health Questionnaire - 9 (PHQ-9) [ minimum score: 0 ; maximum score: 27 ] [More score = worse symptoms]
Measured: From enrollment to the end of treatment at 14th week , 22th week
Secondary outcomes (2)
Anxiety Symptoms
Measured by Generalised Anxiety Disorder - 7 (GAD-7) [min score: 0 , max score: 21] [more score, worse symptoms]
Measured: From enrollment to the end of treatment at 14th week, and 22week
Loneliness
Measured by the Three-Items Loneliness [min 0, max: 9] [more score, more lonely]
Measured: From enrollment to the end of treatment at 14th week, and 22 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Oct 2023
- Study start23 Oct 2023
- Primary completion3 Feb 2025
- Study completion3 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Depression, AnxietyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 72 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidad de San Martín de Porres
- Sponsor type
- University, hospital or other
- Collaborators
- Asociacion Benefica Prisma, Johns Hopkins University, University of Washington
- Responsible party
- Sponsor
- Investigators
- Oscar Flores-Flores, MD, MSc, Principal investigator, Universidad de San Martin de Porres
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06065020
- Sponsor's protocol ID
- E10012021018
- Other IDs
- K43TW011586
- Acronym
- VIDACTIVA1
- Status last verified
- Sep 2026
- First submitted
- 26 Sep 2023
- Last updated
- 16 Sep 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Once first manuscript using data is published.
Publications
Cruz-Riquelme T, Zevallos-Morales A, Carrion I, Otero-Oyague D, Patino V, Lastra D, Valle R, Parodi JF, Pollard SL, Steinman L, Gallo JJ, Flores-Flores O. Pilot trial protocol: community intervention to improve depressive symptoms among Peruvian older adults. Pilot Feasibility Stud. 2024 Aug 22;10(1):112. doi: 10.1186/s40814-024-01540-1.
PubMed 39175082Otero-Oyague D, Lastra Landa D, Patino V, Carrion I, Cruz-Riquelme T, Pollard SL, Parodi JF, Steinman L, Gallo JJ, Valle R, Castro N, Flores-Flores O. Community health workers fostering trust and engagement in a community-based intervention for depressive older adults in Peru: a qualitative study. BMC Health Serv Res. 2026 Feb 21;26(1):418. doi: 10.1186/s12913-026-14130-z.
PubMed 41723436Otero-Oyague D, Lastra D, Patino V, Carrion I, Cruz-Riquelme T, Pollard SL, Parodi JF, Steinman L, Gallo JJ, Valle R, Castro N, Flores-Flores O. Community health workers fostering trust and engagement in a community-based intervention for depressive older adults in Peru: a qualitative study. Res Sq [Preprint]. 2025 Oct 19:rs.3.rs-7665993. doi: 10.21203/rs.3.rs-7665993/v1.
PubMed 41282139
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pilot Trial of an Evidence-based Community Intervention to Improve Depressive Symptoms Among Peruvian Older Adults
- ClinicalTrials.gov ID
- NCT06065020
- Acronym / sponsor ID
- VIDACTIVA1 / E10012021018
- Conditions
- Depression, Anxiety
- Keywords
- depression, aged, problem-solving
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 72 participants (actual)
- Lead sponsor
- Universidad de San Martín de PorresUniversity, hospital or other
- Collaborators
- Asociacion Benefica Prisma, Johns Hopkins University, University of Washington
- Study start
- 23 Oct 2023 (actual)
- Primary completion
- 3 Feb 2025 (actual)
- Study completion
- 3 Feb 2025 (actual)
- First posted
- 3 Oct 2023 (actual)
- Results
- Posted 16 Sep 2026
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this pilot trial is to test how feasible is to conduct a large clinical trial that evaluate both implementation and effectiveness outcomes of a community-based interventions for older adults with depression in low-resource urban settings from Lima, Peru.
The main questions:
Is the way we are planning the study, including those who are taking part and what they will do, good for a large study?
Is the interventional package we are developing good the way it is, and can it be done the way we planned it?
Detailed description
Participants who join will be split into two groups: one group will get the interventional program, and the other group will get standard care. In the interventional group, community health workers will meet with participants eight times to do activities and talk about how they feel. The standard group will have two visits where they will learn things about mental health.
The results of the study will help the researchers understand whether they can test the program in larger study. Additionally, see whether those participants in the interventional group feel better than those who are in the standard group.
Sample size: This is a pilot trial. No sample size calculations are needed because the objective is NOT to evaluate the effect of the intervention, but rather the feasibility of conducting a large-scale clinical trial. It is expected to enroll 64 participants (32 control group vs 32 intervention group). This number is based on previous formative study and training of community health workers.
Researchers will collect basic information to assess feasibility for a larger trial, including:
- Number of potential participants screened per month;
- Number of participants enroled per month;
- Average time from enrolment to randomisation.
- Average time to reach enrolment goal
- Proportion of eligible participants who enrol
- Proportion of people who maintain the study in both groups.
- Reasons for abandoning the study.
- Visit durations
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Behavioral: VIDACTIVA sessionsVIDACTIVA program |
| Control group | Active comparator | Behavioral: Standard CareStandard Care |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Having depressive symptoms (score equal to or greater than 6 on the Patient Health Questionnaire - PHQ 9).
- Capacity to give consent.
- Current residence in Villa El Salvador, Lima, Peru.
Key exclusion criteria (3 listed)
- Previous diagnosis of bipolar disorder
- History of substance abuse
- History of dissociative disorder, psychosis or dementia, or moderate memory and/or cognition problems.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| VIDACTIVA sessionsCommunity health workers (CHWs) will delivered VIDACTIVA intervention that consists in 8 home-sessions, one hour duration, within a period of 14 weeks + 2 follow-up calls (monthly). In total, a period of 22 weeks. The multicomponent intervention consist in the following: Problem-Solving Exercises: These are basic structured exercises aimed at training older individuals in problem-solving. This activity is centered around the older adult, meaning the older adults guides this activity, and the CHWs is a facilitator. Physical Activation: This component involves planning and "scheduling" enjoyable activities (physical or social) that the older adult chooses based on their preferences and capabilities. Education on Depressive Symptoms (psychoeducation) | Behavioural | Intervention group |
| Standard CareStudy fieldworkers will provide 2 educational sessions (45-60 min) about mental health at old age and participant will be guided to mental health community services (primary care centers). One session after the enrolment (week 1) and one at the 14th week. | Behavioural | Control group |
Primary outcome
Depressive Symptoms
Time frame: From enrollment to the end of treatment at 14th week , 22th week
Measured by Patient Health Questionnaire - 9 (PHQ-9) [ minimum score: 0 ; maximum score: 27 ] [More score = worse symptoms]
2 secondary outcomes
Anxiety Symptoms
Time frame: From enrollment to the end of treatment at 14th week, and 22week
Loneliness
Time frame: From enrollment to the end of treatment at 14th week, and 22 week
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Results publication: PubMed 39175082Cruz-Riquelme T, Zevallos-Morales A, Carrion I, Otero-Oyague D, Patino V, Lastra D, Valle R, Parodi JF, Pollard SL, Steinman L, Gallo JJ, Flores-Flores O. Pilot trial protocol: community intervention to improve depressive symptoms among Peruvian older adults. Pilot Feasibility Stud. 2024 Aug 22;10(1):112. doi: 10.1186/s40814-024-01540-1.
- Derived from this study: PubMed 41723436Otero-Oyague D, Lastra Landa D, Patino V, Carrion I, Cruz-Riquelme T, Pollard SL, Parodi JF, Steinman L, Gallo JJ, Valle R, Castro N, Flores-Flores O. Community health workers fostering trust and engagement in a community-based intervention for depressive older adults in Peru: a qualitative study. BMC Health Serv Res. 2026 Feb 21;26(1):418. doi: 10.1186/s12913-026-14130-z.
- Derived from this study: PubMed 41282139Otero-Oyague D, Lastra D, Patino V, Carrion I, Cruz-Riquelme T, Pollard SL, Parodi JF, Steinman L, Gallo JJ, Valle R, Castro N, Flores-Flores O. Community health workers fostering trust and engagement in a community-based intervention for depressive older adults in Peru: a qualitative study. Res Sq [Preprint]. 2025 Oct 19:rs.3.rs-7665993. doi: 10.21203/rs.3.rs-7665993/v1.
- Individual participant dataSharing planned: Yes. Once first manuscript using data is published.
Related trials for Depression, Anxiety
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Recruiting
Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
Risk of Depression and Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Oscar Flores-Flores, MD, MSc principal investigator
Universidad de San Martin de Porres
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing VIDACTIVA sessions in people with Depression, Anxiety, run by Universidad de San Martín de Porres at 1 site in Peru.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Peru. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 16 Sep 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Depressive Symptoms (time frame: From enrollment to the end of treatment at 14th week , 22th week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06065020, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.